secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcus Biosciences, Inc. (RCUS)
CIK:        0001724521
Form:       8-K
Filed at:   2023-06-28T23:59:59+00:00
Accession:  0000950170-23-030273
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Arcus Biosciences sells 1.01M shares to Gilead at $19.26 per share under amended purchase agreement
--------------------------------------------------------------------------------

- Gilead to purchase 1,010,000 shares of Arcus common stock at $19.26 per share.
- Agreement amends 2021 SPA; Gilead retains option to buy up to 35% of outstanding shares until July 2025.
- Shares sold in unregistered transaction under Section 4(a)(2) to accredited investor Gilead.
- Closing subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1724521/000095017023030273/0000950170-23-030273-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1724521/000095017023030273/rcus-20230627.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-030273

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer